Drug intelligence / Profile preview

sulfoxone

Development stage
Discontinued
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Sulfoxone is a water-soluble sulfone and synthetic sulfonamide antibiotic primarily used as an antileprosy drug. It has also been used with limited success in the treatment of dermatitis herpetiformis and was at times considered for pulmonary tuberculosis. Sulfoxone acts as a competitive inhibitor of the bacterial enzyme dihydropteroate synthetase, blocking the binding of para-aminobenzoic acid (PABA) and thereby inhibiting folic acid synthesis essential for bacterial growth. This mechanism renders it bacteriostatic against most gram-positive and many gram-negative organisms. The drug is rapidly absorbed orally, widely distributed in tissues, metabolized hepatically, and has an elimination half-life of 3–8 hours. Its use under the brand name Diasone has been discontinued.

Brand names
diasone
Other names
aldesulfonealdesulphonesulfoxone sodiumadesulfone sodium
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on sulfoxone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sulfoxone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call